| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |